Tumor cell culture survival following glucose and glutamine deprivation at typical physiological concentrations

被引:26
作者
Mathews, Edward Henry [1 ]
Stander, B. Andre [2 ]
Joubert, Annie M. [2 ]
Liebenberg, Leon [1 ]
机构
[1] North West Univ, Ctr Res & Continued Engn Dev, Lynnwood Ridge, South Africa
[2] Univ Pretoria, Fac Hlth Sci, Sch Med, Dept Physiol, ZA-0002 Pretoria, South Africa
关键词
Glucose deprivation; HeLa cell survival and morphology; Metabolic cancer control; OXIDATIVE STRESS; FREE-RADICALS; SUGAR-FREE; CANCER; RESTRICTION; ANTIOXIDANTS; INHIBITION; METABOLISM; RESISTANCE; METFORMIN;
D O I
10.1016/j.nut.2013.07.024
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: Most glucose (and glutamine)-deprivation studies of cancer cell cultures focus on total depletion, and are conducted over at least 24 h. It is difficult to extrapolate findings from such experiments to practical anti-glycolytic treatments, such as with insulin-inhibiting diets (with 10%-50% carbohydrate dietary restriction) or with isolated limb perfusion therapy (which usually lasts about 90 min). The aim of this study was to obtain experimental data on the effect of partial deprivation of D-glucose and L-glutamine (to typical physiological concentrations) during 0 to 6-h exposures of HeLa cells. Methods: HeLa cells were treated for 0 to 6 h with 6 mM D-glucose and 1 mM c-glutamine (normal in vivo conditions), 3 mM D-glucose and 0.5 mM L-glutamine (severe hypoglycemic conditions), and 0 mM D-glucose and 0 mM L-glutamine ("starvation"). Polarization-optical differential interference contrast and phase-contrast light microscopy were employed to investigate morphologic changes. Results: Reduction of glucose levels from 6 to 3 mM (and glutamine levels from 1 to 0.5 mM) brings about cancer cell survival of 73% after 2-h exposure and 63% after 4-h exposure. Reducing glucose levels from 6 to 0 mM (and glutamine levels from 1 to 0 mM) for 4 h resulted in 53% cell survival. Conclusion: These data reveal that glucose (and glutamine) deprivation to typical physiological concentrations result in significant cancer cell killing after as little as 2 h. This supports the possibility of combining anti-glycolytic treatment, such as a carbohydrate-restricted diet, with chemotherapeutics for enhanced cancer cell killing. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:218 / 227
页数:10
相关论文
共 36 条
[1]   Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation [J].
Aykin-Burns, Nukhet ;
Ahmad, Iman M. ;
Zhu, Yueming ;
Oberley, Larry W. ;
Spitz, Douglas R. .
BIOCHEMICAL JOURNAL, 2009, 418 :29-37
[2]   Survival of the fittest: metabolic adaptations in cancer [J].
Berardi, Marcelo J. ;
Fantin, Valeria R. .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2011, 21 (01) :59-66
[3]   Metformin and cancer therapy [J].
Bost, Frederic ;
Ben Sahra, Issam ;
Le Marchand-Brustel, Yannick ;
Tanti, Jean-Francois .
CURRENT OPINION IN ONCOLOGY, 2012, 24 (01) :103-108
[4]   Signaling for death: tyrosine phosphorylation in the response to glucose deprivation [J].
Bryson, Bryan D. ;
White, Forest M. .
MOLECULAR SYSTEMS BIOLOGY, 2012, 8
[5]   A Perspective on Cancer Cell Metastasis [J].
Chaffer, Christine L. ;
Weinberg, Robert A. .
SCIENCE, 2011, 331 (6024) :1559-1564
[6]   Reactive oxygen species, cellular redox systems, and apoptosis [J].
Circu, Magdalena L. ;
Aw, Tak Yee .
FREE RADICAL BIOLOGY AND MEDICINE, 2010, 48 (06) :749-762
[7]   Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys [J].
Colman, Ricki J. ;
Anderson, Rozalyn M. ;
Johnson, Sterling C. ;
Kastman, Erik K. ;
Kosmatka, Kristopher J. ;
Beasley, T. Mark ;
Allison, David B. ;
Cruzen, Christina ;
Simmons, Heather A. ;
Kemnitz, Joseph W. ;
Weindruch, Richard .
SCIENCE, 2009, 325 (5937) :201-204
[8]   Links between metabolism and cancer [J].
Dang, Chi V. .
GENES & DEVELOPMENT, 2012, 26 (09) :877-890
[9]  
Danz R., 2004, PHOTONIK, V1, P42
[10]   Sugar-free approaches to cancer cell killing [J].
El Mjiyad, N. ;
Caro-Maldonado, A. ;
Ramirez-Peinado, S. ;
Munoz-Pinedo, C. .
ONCOGENE, 2011, 30 (03) :253-264